Literature DB >> 21822026

Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis.

Tzu-Yun McDowell1, Sania Amr, William J Culpepper, Patricia Langenberg, Walter Royal, Christopher Bever, Douglas D Bradham.   

Abstract

BACKGROUND: Early life events have been suggested to influence multiple sclerosis (MS) susceptibility, and to potentially modulate its clinical course. We assessed vitamin D-related exposures from childhood to disease onset and their associations with MS progression.
METHODS: Among veterans in the Multiple Sclerosis Surveillance Registry, 219 reported having the progressive form and met the inclusion criteria. Participants reported their past sun exposure, vitamin D-related intake and age at disability milestones using the Patient-Determined Disease Steps (PDDS). The Cox proportional hazards model was used to examine the association between vitamin D-related exposures and time (years) to disability.
RESULTS: Low average sun exposure in the fall/winter before disease onset was associated with an increased risk of progressing to a PDDS score of 8 (hazard ratio, HR: 2.13, 95% confidence interval, CI: 1.20-3.78), whereas use of cod liver oil during childhood and adolescence was associated with a reduced risk (HR: 0.44, 95% CI: 0.20-0.96).
CONCLUSIONS: These results suggest that exposure to vitamin D before MS onset might slow disease-related neurodegeneration and thus delay progression to disability among patients with the progressive subtype.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822026     DOI: 10.1159/000329258

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

Review 1.  Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.

Authors:  Alessandro Maglione; Miriam Zuccalà; Martina Tosi; Marinella Clerico; Simona Rolla
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

Review 2.  Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.

Authors:  Priscilla Koduah; Friedemann Paul; Jan-Markus Dörr
Journal:  EPMA J       Date:  2017-11-15       Impact factor: 6.543

Review 3.  The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.

Authors:  Alessandro Maglione; Simona Rolla; Stefania Federica De Mercanti; Santina Cutrupi; Marinella Clerico
Journal:  Cells       Date:  2019-10-19       Impact factor: 6.600

4.  A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment.

Authors:  J Aivo; B-M Lindsröm; M Soilu-Hänninen
Journal:  Mult Scler Int       Date:  2012-08-05

5.  Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

Authors:  Jan Dörr; Andrea Döring; Friedemann Paul
Journal:  EPMA J       Date:  2013-01-29       Impact factor: 6.543

6.  Consensus statement from 2nd International Conference on Controversies in Vitamin D.

Authors:  A Giustina; R A Adler; N Binkley; J Bollerslev; R Bouillon; B Dawson-Hughes; P R Ebeling; D Feldman; A M Formenti; M Lazaretti-Castro; C Marcocci; R Rizzoli; C T Sempos; J P Bilezikian
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

Review 7.  The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?

Authors:  Daniel S Smyk; Athanasios Mavropoulos; Giorgina Mieli-Vergani; Diego Vergani; Marco Lenzi; Dimitrios P Bogdanos
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.